APTV vs TRDA · P/E 41, rev $19.71B vs P/E 12, rev $210.8M
Aptiv PLC (APTV) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Aptiv PLC (APTV) is a auto parts company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported APTV revenue for 2024-12-31 was $19.71B. Net income was $275.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. APTV currently screens at market cap $14.52B and trailing P/E 40.8.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
APTV currently screens at market cap $14.52B and trailing P/E 40.8. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the APTV and TRDA stock pages for the full models.
Not investment advice.